Metropolis Healthcare Ltd
NSE:METROPOLIS

Watchlist Manager
Metropolis Healthcare Ltd Logo
Metropolis Healthcare Ltd
NSE:METROPOLIS
Watchlist
Price: 2 061.85 INR 2.32% Market Closed
Market Cap: 105.7B INR
Have any thoughts about
Metropolis Healthcare Ltd?
Write Note

Metropolis Healthcare Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Metropolis Healthcare Ltd
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Metropolis Healthcare Ltd
NSE:METROPOLIS
Cash from Investing Activities
-â‚ą894.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Agarwal's Eye Hospital Ltd
BSE:526783
Cash from Investing Activities
-â‚ą700.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thyrocare Technologies Ltd
NSE:THYROCARE
Cash from Investing Activities
-â‚ą912.8m
CAGR 3-Years
-22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
Cash from Investing Activities
-â‚ą2.1B
CAGR 3-Years
-15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vijaya Diagnostic Centre Ltd
NSE:VIJAYA
Cash from Investing Activities
-â‚ą1.4B
CAGR 3-Years
-3%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Krsnaa Diagnostics Ltd
NSE:KRSNAA
Cash from Investing Activities
-â‚ą1.3B
CAGR 3-Years
-28%
CAGR 5-Years
8%
CAGR 10-Years
N/A
No Stocks Found

Metropolis Healthcare Ltd
Glance View

Market Cap
105.6B INR
Industry
Health Care

Metropolis Healthcare Ltd. owns and operates medical laboratories. The company is headquartered in Gurgaon, Haryana and currently employs 4,532 full-time employees. The company went IPO on 2019-04-15. The firm offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and monitoring of the disease. The firm also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The firm offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. The company owns a chain of diagnostic centers across India, South Asia, Africa and the Middle East. The firm has spread its footprint across 20 Indian states and over 210 cities.

METROPOLIS Intrinsic Value
1 440.76 INR
Overvaluation 30%
Intrinsic Value
Price

See Also

What is Metropolis Healthcare Ltd's Cash from Investing Activities?
Cash from Investing Activities
-894.1m INR

Based on the financial report for Jun 30, 2024, Metropolis Healthcare Ltd's Cash from Investing Activities amounts to -894.1m INR.

Back to Top